OBJECTIVES: In acute myocardial infarction, cardiovascular magnetic resonance (CMR) allows for quantifying the extent of salvaged myocardium after reperfusion as a potential strong end point for clinical trials. The aim of this study was to investigate whether the early prognostic significance of myocardial salvage assessed by CMR is sustained at long-term clinical follow-up in patients with ST-elevation myocardial infarction (STEMI) undergoing primary angioplasty.
METHODS: analysed 208 consecutive patients with STEMI undergoing primary angioplasty
RESULTS: The median MSI was 48 (IQR 27 to 73). Long-term follow-up was available in 202 patients (97%) at a median of 18.5 months (IQR 13.8 to 20.8). Major adverse cardiovascular events occurred in 33 patients (16%), with a significantly lower event rate in the MSI ≥ median group (7 vs 26 events, p
CONCLUSIONS: MSI assessed by CMR predicts long-term clinical outcome in acute reperfused STEMI. Therefore, our data support the use of myocardial salvage as an end point for clinical trials investigating novel reperfusion strategies.
Cardiopulmonary Imaging, Section Head
Cleveland Clinic Florida
Latest posts by Jacobo Kirsch (see all)
- Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus - August 24, 2016
- Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis - August 24, 2016
- State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes - August 15, 2016